In a tight, historically costly presidential election, both candidates are seeking the support of powerful business interests. That raises concerns that tough novel antitrust enforcement under President Joe Biden will be short-lived.
AND a huge, bipartisan majority Americans support the enforcement of laws aimed at curbing anti-competitive abuses. But the candidates are not saying whether they will keep a key antitrust official in office, while some of the billionaires replacing Vice President Kamala Harris have openly called for the official’s removal.
The two main antitrust agencies, the Federal Trade Commission and the Justice Department’s Antitrust Division, are taking high-profile steps to reverse a decades-long trend in which Republican and Democratic administrations have allowed most corporate megamergers to thrive.
Their novel enforcement includes FTC Investigation of Massive Pharmaceutical Intermediariesthe lawsuit the agency filed against them insulin pricing practiceslawsuit to cease and desist proposed a merger of grocery giants Kroger and Albertsonsand attack on technology companies such as Google. For his part, he is suing the Antitrust Division of the Department of Justice break up Live Nation Entertainment, owner of Ticketmaster.
Before several years of vigorous novel enforcement, regulators largely kept their hands off companies looking to buy off and get bigger.
The major antitrust laws were passed at the turn of the 20th century and during the Great Depression. Alvaro Bedoya, a member of the Federal Trade Commission, told the Capital Journal in 2022 that their goal was honesty — especially for average people, miniature businesses and miniature farmers.
But since the delayed 1940s, some at the University of Chicago Law School have argued that the laws actually have a very different purpose— economic efficiency. They didn’t care how massive the company was, as long as they perceived it as more effective.
Their student, former US Attorney General Robert Bork, published in 1978 book making the same arguments, and the Reagan administration adopted some of them when it took office in 1981. Subsequent administrations have mostly been I don’t like telling companies this that they can’t grow as massive as they want or however they want.
Some of the resulting conglomerates have become so unwieldy that they are considering a voluntary breakup.
For example, the Trump administration in 2019 CVS Health OK’d Aetna acquisitionleading health insurer. The conglomerate also owns the nation’s largest chain of brick-and-mortar pharmacies, the largest pharmacy benefits manager and a gigantic mail-order pharmacy, and being a health care provider plays a gigantic role.
Now, under pressure from investors, CVS is considering that option cutting out Aetnahis Pharmacy Benefits Manager, CVS Caremarkor other parts or groups of parts of its operation.
Forbes’ reasons for the split include “increased government control over Caremark.”
This is the company’s pharmacy benefits manager, or PBM for tiny. It and two other gigantic intermediaries – Express Scripts and OptumRx – control access to approximately 80% of insured patients in the United States and have been accused of illegally profiting through a number of unclear practices.
State legislators, attorneys general and Congress have all scrutinized gigantic PBMs over the past five years. But perhaps the biggest threat facing the industry is the FTC.
As possible evidence of this, Express Scripts filed a lawsuit trying to do just that stop the commission’s investigation to their operations, and all three major PBMs summoned Bedoya, FTC Chair Lina Khan and Commissioner Rebecca Kelly Slaughter withdraw from an insulin suit. The companies say the commissioners are biased because they say the massive and unclear rebates that PBMs take from drugmakers appear to lead to higher list prices and often higher out-of-pocket costs for patients. However, in 2020, the University of Southern California’s Schaeffer Center published a white paper stating this came to the same conclusion.
Health care conglomerates are not the only business titans seeking to put an end to the FTC’s vigorous antitrust enforcement under Khan’s leadership. And while high food and drug prices are a major issue this election, presidential candidates haven’t rushed to defend them.
Two of Harris’ billionaire donors – Barry Diller and Reid Hoffman – called Harris in July if he won. not reappoint Khanwhose term expires this year. Another vital Harris surrogate in the world of massive money, Earlier this month, the Financial Times reported that billionaire views are representative of many on Wall Street and that this is perhaps he will receive a amiable welcome from Harris when he seeks their support. Wealthy people see Trump as superior on taxes and regulations, but many see him as unpredictable.
Meanwhile, they worry that Harris will regulate them too aggressively, and she is trying to composed those fears, the story says. The Financial Times reported that CVS’s Karen Lynch was among the CEOs Harris met.
The Harris campaign did not respond to questions for this story. However, on Thursday, the news organization NOTUS reported that Brian Deese, Harris’ economic adviser, supports Khan’s reappointment.
Republican vice presidential candidate, Ohio Sen. J.D. Vance, said in February that Khan “wasdoing a pretty good job” However, when asked whether the next President Trump would reappoint her, the Trump campaign was noncommittal.
“President Trump announced the formation of a Trump-Vance Transition Leadership Group to begin the process of preparing for what comes after the election,” communications director Steven Cheung said in an email. “But formal discussions about who will rule in a second Trump administration are premature. “President Trump will pick the best people for his Cabinet to undo all the damage that the dangerously liberal Kamala Harris has done to our country.”
Sen. Sherrod Brown, R-Ohio, is a fierce critic of what he sees as consumer abuses by PBMs and other massive companies. His office was a little more supportive of Khan.
“dream. “Brown voted with a majority of his Senate colleagues to confirm Lina Khan as FTC Commissioner in 2021.” – his employees wrote in an e-mail. “As always, Senator Brown will give each presidential candidate the tough and fair look the Constitution requires.”
His Republican opponent Bernie Moreno’s campaign did not respond to a question about the FTC chairman position.
YOU MAKE OUR WORK POSSIBLE.
